NEXT Financial Group, Inc - PDL BIOPHARMA INC ownership

Back to all holdings Add to watchlist

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 215 filers reported holding PDL BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
NEXT Financial Group, Inc ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2015$17,000
-22.7%
3,5000.0%0.01%
-25.0%
Q2 2015$22,000
-8.3%
3,5000.0%0.01%0.0%
Q1 2015$24,000
-80.0%
3,500
-77.5%
0.01%
-80.0%
Q4 2014$120,000
+90.5%
15,550
+82.9%
0.04%
+207.7%
Q3 2014$63,000–8,500–0.01%–
 Download
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2015
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders